Protagenic Therapeutics, Inc. announced that at the Annual Meeting of Stockholders held on November 23, 2022 approved the election of Timothy R. Wright as a Class I director to serve their terms until the Company's 2025 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +7.23% | +15.50% | +50.51% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.51% | 6.61M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.94% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- PTIX Stock
- News Protagenic Therapeutics, Inc.
- Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director